Ra Medical Systems to Participate in Upcoming Virtual Investment Conferences

Rhea-AI Summary

Ra Medical Systems (NYSE American: RMED), a medical device firm, will participate in two virtual investment conferences: the 33rd Annual Roth Conference from March 15-17, 2021, with virtual investor meetings, and the Maxim 2021 Emerging Growth Virtual Conference from March 17-19, 2021, where CEO Will McGuire will present a company overview. The corporate presentation is accessible on their website. Ra Medical specializes in excimer lasers and catheters for treating vascular and dermatological conditions, with FDA-cleared products like the DABRA and Pharos systems.

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will participate in two upcoming virtual investment conferences:

• 33^rd Annual Roth Conference being held March 15-17, 2021. Ra Medical will hold virtual investor meetings. Investors interested in arranging a meeting should contact their Roth Capital Partners sales representative or LHA Investor Relations. Roth Conference information is available here.

• Maxim 2021 Emerging Growth Virtual Conference being held March 17-19, 2021. Ra Medical CEO Will McGuire will present a company overview during the conference. Investors can register for the conference here.

Ra Medical’s corporate presentation is available on the Company’s website here.

About Ra Medical Systems

Ra Medical Systems commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017 the DABRA excimer laser system received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions, or CTOs, in patients with symptomatic infrainguinal lower extremity vascular disease with an intended use for ablating a channel in occlusive peripheral vascular disease. The Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are both based on Ra Medical’s core excimer laser technology platform and deploy similar mechanisms of action. Ra Medical manufactures DABRA and Pharos excimer lasers and catheters in a 32,000-square-foot facility located in Carlsbad, Calif. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in controlled environments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210311005297/en/

FAQ

What is Ra Medical Systems' participation in the Roth Conference?

Ra Medical Systems will hold virtual investor meetings during the 33rd Annual Roth Conference from March 15-17, 2021.

When is the Maxim 2021 Emerging Growth Virtual Conference?

The Maxim 2021 Emerging Growth Virtual Conference will take place from March 17-19, 2021.

Who will represent Ra Medical at the Maxim Conference?

Ra Medical CEO Will McGuire will present a company overview at the Maxim 2021 Emerging Growth Virtual Conference.

Where can I find Ra Medical Systems' corporate presentation?

The corporate presentation of Ra Medical Systems is available on their website.

What technologies does Ra Medical Systems focus on?

Ra Medical Systems specializes in excimer lasers and catheters for treating vascular and dermatological diseases.

What FDA-cleared products does Ra Medical offer?

Ra Medical offers FDA-cleared products like the DABRA excimer laser system and the Pharos excimer laser system.